CompletedNCT01528839
L-Thyroxine or Placebo Added for Depression Related to Bipolarity
About this title
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Read the official source — NCT01528839Medication studyAges 18–65United States + Germany
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Los Angeles and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateMarch 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 74
- Sponsor
- Charite University, Berlin, Germany
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States, Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01528839
- Official title
Show the full official title
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles, United States · Berlin, Germany · Bochum, Germany
2 more locations
- Dresden, Germany
- Göttingen, Germany
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Charite University, Berlin, Germany, a university.
Did this study involve medication?
Yes. The study involved medication, including L-Thyroxine and Placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
